The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Cystic Fibrosis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Drugs.
Report Scope
The Cystic Fibrosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cystic Fibrosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cystic Fibrosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Actavis
- F. Hoffmann-La Roche
- Gilead Sciences
- Novartis
- Vertex Pharmaceuticals
- Abbott
- Anthera Pharmaceuticals
- Arcturus Therapeutics
- Boehringer Ingelheim
- Chiesi Farmaceutici
- Corbus Pharmaceuticals
- Genzyme
- Insmed
- Johnson & Johnson
- Merck Sharp & Dohme
- Neovii Biotech
- Novo Nordisk
- PharmaSwiss
- Pharmaxis
- Proteostasis Therapeutics
- PTC Therapeutics
- United Medical
- Venus Remedies
Segment by Type
- Oral Cystic Fibrosis Drugs
- Injection Cystic Fibrosis Drugs
Segment by Application
- Hospitals
- Clinics
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cystic Fibrosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cystic Fibrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Cystic Fibrosis Drugs Market Overview
1.1 Product Overview and Scope of Cystic Fibrosis Drugs
1.2 Cystic Fibrosis Drugs Segment by Type
1.2.1 Global Cystic Fibrosis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Cystic Fibrosis Drugs
1.2.3 Injection Cystic Fibrosis Drugs
1.3 Cystic Fibrosis Drugs Segment by Application
1.3.1 Global Cystic Fibrosis Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Cystic Fibrosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Cystic Fibrosis Drugs Revenue 2019-2030
1.4.2 Global Cystic Fibrosis Drugs Sales 2019-2030
1.4.3 Global Cystic Fibrosis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cystic Fibrosis Drugs Market Competition by Manufacturers
2.1 Global Cystic Fibrosis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cystic Fibrosis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Cystic Fibrosis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cystic Fibrosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cystic Fibrosis Drugs, Product Type & Application
2.7 Cystic Fibrosis Drugs Market Competitive Situation and Trends
2.7.1 Cystic Fibrosis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cystic Fibrosis Drugs Players Market Share by Revenue
2.7.3 Global Cystic Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cystic Fibrosis Drugs Retrospective Market Scenario by Region
3.1 Global Cystic Fibrosis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cystic Fibrosis Drugs Global Cystic Fibrosis Drugs Sales by Region: 2019-2030
3.2.1 Global Cystic Fibrosis Drugs Sales by Region: 2019-2024
3.2.2 Global Cystic Fibrosis Drugs Sales by Region: 2025-2030
3.3 Global Cystic Fibrosis Drugs Global Cystic Fibrosis Drugs Revenue by Region: 2019-2030
3.3.1 Global Cystic Fibrosis Drugs Revenue by Region: 2019-2024
3.3.2 Global Cystic Fibrosis Drugs Revenue by Region: 2025-2030
3.4 North America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.4.1 North America Cystic Fibrosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cystic Fibrosis Drugs Sales by Country (2019-2030)
3.4.3 North America Cystic Fibrosis Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cystic Fibrosis Drugs Market Facts & Figures by Country
3.5.1 Europe Cystic Fibrosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cystic Fibrosis Drugs Sales by Country (2019-2030)
3.5.3 Europe Cystic Fibrosis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cystic Fibrosis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Cystic Fibrosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cystic Fibrosis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Cystic Fibrosis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cystic Fibrosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Cystic Fibrosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cystic Fibrosis Drugs Sales by Country (2019-2030)
3.7.3 Latin America Cystic Fibrosis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cystic Fibrosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cystic Fibrosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cystic Fibrosis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cystic Fibrosis Drugs Sales by Type (2019-2030)
4.1.1 Global Cystic Fibrosis Drugs Sales by Type (2019-2024)
4.1.2 Global Cystic Fibrosis Drugs Sales by Type (2025-2030)
4.1.3 Global Cystic Fibrosis Drugs Sales Market Share by Type (2019-2030)
4.2 Global Cystic Fibrosis Drugs Revenue by Type (2019-2030)
4.2.1 Global Cystic Fibrosis Drugs Revenue by Type (2019-2024)
4.2.2 Global Cystic Fibrosis Drugs Revenue by Type (2025-2030)
4.2.3 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Cystic Fibrosis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cystic Fibrosis Drugs Sales by Application (2019-2030)
5.1.1 Global Cystic Fibrosis Drugs Sales by Application (2019-2024)
5.1.2 Global Cystic Fibrosis Drugs Sales by Application (2025-2030)
5.1.3 Global Cystic Fibrosis Drugs Sales Market Share by Application (2019-2030)
5.2 Global Cystic Fibrosis Drugs Revenue by Application (2019-2030)
5.2.1 Global Cystic Fibrosis Drugs Revenue by Application (2019-2024)
5.2.2 Global Cystic Fibrosis Drugs Revenue by Application (2025-2030)
5.2.3 Global Cystic Fibrosis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Cystic Fibrosis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Actavis
6.1.1 Actavis Corporation Information
6.1.2 Actavis Description and Business Overview
6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Actavis Cystic Fibrosis Drugs Product Portfolio
6.1.5 Actavis Recent Developments/Updates
6.2 F. Hoffmann-La Roche
6.2.1 F. Hoffmann-La Roche Corporation Information
6.2.2 F. Hoffmann-La Roche Description and Business Overview
6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
6.3 Gilead Sciences
6.3.1 Gilead Sciences Corporation Information
6.3.2 Gilead Sciences Description and Business Overview
6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
6.3.5 Gilead Sciences Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Cystic Fibrosis Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Vertex Pharmaceuticals
6.5.1 Vertex Pharmaceuticals Corporation Information
6.5.2 Vertex Pharmaceuticals Description and Business Overview
6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.5.5 Vertex Pharmaceuticals Recent Developments/Updates
6.6 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Abbott Cystic Fibrosis Drugs Product Portfolio
6.6.5 Abbott Recent Developments/Updates
6.7 Anthera Pharmaceuticals
6.6.1 Anthera Pharmaceuticals Corporation Information
6.6.2 Anthera Pharmaceuticals Description and Business Overview
6.6.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.7.5 Anthera Pharmaceuticals Recent Developments/Updates
6.8 Arcturus Therapeutics
6.8.1 Arcturus Therapeutics Corporation Information
6.8.2 Arcturus Therapeutics Description and Business Overview
6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.8.5 Arcturus Therapeutics Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Chiesi Farmaceutici
6.10.1 Chiesi Farmaceutici Corporation Information
6.10.2 Chiesi Farmaceutici Description and Business Overview
6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
6.10.5 Chiesi Farmaceutici Recent Developments/Updates
6.11 Corbus Pharmaceuticals
6.11.1 Corbus Pharmaceuticals Corporation Information
6.11.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Description and Business Overview
6.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
6.11.5 Corbus Pharmaceuticals Recent Developments/Updates
6.12 Genzyme
6.12.1 Genzyme Corporation Information
6.12.2 Genzyme Cystic Fibrosis Drugs Description and Business Overview
6.12.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
6.12.5 Genzyme Recent Developments/Updates
6.13 Insmed
6.13.1 Insmed Corporation Information
6.13.2 Insmed Cystic Fibrosis Drugs Description and Business Overview
6.13.3 Insmed Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Insmed Cystic Fibrosis Drugs Product Portfolio
6.13.5 Insmed Recent Developments/Updates
6.14 Johnson & Johnson
6.14.1 Johnson & Johnson Corporation Information
6.14.2 Johnson & Johnson Cystic Fibrosis Drugs Description and Business Overview
6.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
6.14.5 Johnson & Johnson Recent Developments/Updates
6.15 Merck Sharp & Dohme
6.15.1 Merck Sharp & Dohme Corporation Information
6.15.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Description and Business Overview
6.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
6.15.5 Merck Sharp & Dohme Recent Developments/Updates
6.16 Neovii Biotech
6.16.1 Neovii Biotech Corporation Information
6.16.2 Neovii Biotech Cystic Fibrosis Drugs Description and Business Overview
6.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
6.16.5 Neovii Biotech Recent Developments/Updates
6.17 Novo Nordisk
6.17.1 Novo Nordisk Corporation Information
6.17.2 Novo Nordisk Cystic Fibrosis Drugs Description and Business Overview
6.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
6.17.5 Novo Nordisk Recent Developments/Updates
6.18 PharmaSwiss
6.18.1 PharmaSwiss Corporation Information
6.18.2 PharmaSwiss Cystic Fibrosis Drugs Description and Business Overview
6.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
6.18.5 PharmaSwiss Recent Developments/Updates
6.19 Pharmaxis
6.19.1 Pharmaxis Corporation Information
6.19.2 Pharmaxis Cystic Fibrosis Drugs Description and Business Overview
6.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
6.19.5 Pharmaxis Recent Developments/Updates
6.20 Proteostasis Therapeutics
6.20.1 Proteostasis Therapeutics Corporation Information
6.20.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Description and Business Overview
6.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.20.5 Proteostasis Therapeutics Recent Developments/Updates
6.21 PTC Therapeutics
6.21.1 PTC Therapeutics Corporation Information
6.21.2 PTC Therapeutics Cystic Fibrosis Drugs Description and Business Overview
6.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.21.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
6.21.5 PTC Therapeutics Recent Developments/Updates
6.22 United Medical
6.22.1 United Medical Corporation Information
6.22.2 United Medical Cystic Fibrosis Drugs Description and Business Overview
6.22.3 United Medical Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.22.4 United Medical Cystic Fibrosis Drugs Product Portfolio
6.22.5 United Medical Recent Developments/Updates
6.23 Venus Remedies
6.23.1 Venus Remedies Corporation Information
6.23.2 Venus Remedies Cystic Fibrosis Drugs Description and Business Overview
6.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
6.23.5 Venus Remedies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cystic Fibrosis Drugs Industry Chain Analysis
7.2 Cystic Fibrosis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cystic Fibrosis Drugs Production Mode & Process
7.4 Cystic Fibrosis Drugs Sales and Marketing
7.4.1 Cystic Fibrosis Drugs Sales Channels
7.4.2 Cystic Fibrosis Drugs Distributors
7.5 Cystic Fibrosis Drugs Customers
8 Cystic Fibrosis Drugs Market Dynamics
8.1 Cystic Fibrosis Drugs Industry Trends
8.2 Cystic Fibrosis Drugs Market Drivers
8.3 Cystic Fibrosis Drugs Market Challenges
8.4 Cystic Fibrosis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
